If you need more lookups,
subscriptions start at $34 USD/month.
Jeff Hermes Location
New York, NY, US
Jeff Hermes Work
Executive Vice President @ (November 2022 - Present)
Vice President @ (June 2021 - October 2022)
Head of In Vitro Pharmacology @ (September 2020 - June 2021)
President @ Hermes Biosolutions LLC (April 2019 - September 2020)
Head of Screening and Translational Enzymology @ (February 2017 - March 2019)
Executive Director and North Wales Site Head @ (September 2010 - December 2016)
Sr. Director @ (April 2005 - September 2010)
Site Lead, In Vitro Sciences - Rahway @ (January 2009 - November 2009)
Site Lead, Automated Biotechnology @ (July 2008 - December 2008)
Interim Head of Automated Biotechnology, North Wales @ (June 2008 - December 2008)
Jeff Hermes Education
Harvard University
Postdoctoral Fellowship (Chemistry)
1984-1988
University of Wisconsin-Madison
PhD (Biochemistry)
1979-1983
University of Wisconsin-Parkside
BS (Chemistry)
1975-1979
Jeff Hermes Skills
Biotechnology
High Throughput Screening
Drug Discovery
In Vitro
Protein Chemistry
Translational Medicine
Lead Change
Biomarkers
Laboratory
R&D
Assay Development
Lifesciences
Clinical Development
Science
Oncology
Technology Transfer
Infectious Diseases
Drug Development
Pharmaceutical Industry
Biochemistry
Research and Development (R&D)
Life Sciences
Marketing
Business Strategy
Leadership
Research
Management
Research and Development R&d
Microsoft Excel
Research and Development
Jeff Hermes Summary
Jeff Hermes, based in New York, NY, US, is currently a Executive Vice President at Odyssey Therapeutics. Jeff Hermes brings experience from previous roles at Kallyope, Hermes Biosolutions LLC and Roche. Jeff Hermes holds a 1984 - 1988 Postdoctoral Fellowship in Chemistry @ Harvard University. With a robust skill set that includes Biotechnology, High Throughput Screening, Drug Discovery, In Vitro, Protein Chemistry and more. Jeff Hermes has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Jeff Hermes?
Find contact details for 700 million professionals.